Patnaik, Amita <br/><br/>
Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  09 2018 
 - 419 p.  digital 
<br/><br/> Publication Type: Journal Article; Published Erratum 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-018-3641-5  doi